Ben R Taylor

Chief Financial Officer, Recursion Pharmaceuticals, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$0.2M

Companies

Latest trade

Mar 17, 2026

Companies

Recursion Pharmaceuticals, Inc.Chief Financial Officer −$0.2M

Trades

RXRX Sold 7,956 shares at $3.39 · planned $0.0M Mar 17

RXRX Sold 13,426 shares at $3.08 · planned $0.0M Feb 18

RXRX Sold 21,383 shares at $4.18 · planned $0.1M Dec 29

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.